Neurocrine Biosciences 3Q profit, revenue surge
{ Posted on Oct 31 2011 by Yahoo! Finance: Earnings News }
Neurocrine Biosciences Inc. said Monday that third-quarter jumped sharply as revenue nearly tripled as the company recognized $30 million in revenue for moving a new drug closer to regulatory approval.
Unique in the industry, Macroaxis financial engineering platform delivers measurable value in the form of improved return on your investment portfolios | 

